Ozempic and Your Eyes: What the Data Really Shows episode artwork

EPISODE · Aug 29, 2025 · 7 MIN

Ozempic and Your Eyes: What the Data Really Shows

from Primary Care Voice · host Kulmeet Kundlas M.D.

Ozempic & Vision Loss: Separating Fact from Fiction In this video, Dr. Kulmeet Kundlas examines recent claims linking Ozempic (Semaglutide), a popular diabetes and weight loss medication, to cases of vision loss. The episode explores the specifics of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) and other eye complications potentially associated with Ozempic. Dr. Kundlas provides a balanced view on the current scientific evidence, emphasizing the rarity of these side effects compared to the significant benefits of the drug. Patients and doctors are advised on how to mitigate risks and when to seek medical advice. Stay informed and get a professional perspective on this important health issue.

Episode metadata supplied by the publisher feed · Published Aug 29, 2025

Embed this episode

NOW PLAYING

Ozempic and Your Eyes: What the Data Really Shows

0:00 7:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Primary Care Voice?

This episode is 7 minutes long.

When was this Primary Care Voice episode published?

This episode was published on August 29, 2025.

Can I download this Primary Care Voice episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!